News - Biotechnology
Eisai subsidiary Morphotek and Champions agree research partnership
23 April 2010
Eisai subsidiary Morphotek is to work with Champions Biotechnology on research into Morphotek's monoclonal antibody portfolio for the oncology sector. ...
Click on the link to read the full article at Zenopa (This link will open in a new window)Cellsafe To Expand Biotech Activities In Indonesia
23 April 2010
KUALA LUMPUR, April 23 (Bernama) -- Cellsafe International Group, a regional stem cell biotechnology company, is to expand its biotechnology business and ...
Click on the link to read the full article at Bernama (This link will open in a new window)OrbiMed Participates in $8M Private Placement for Kun Run Biotechnology
23 April 2010
OrbiMed Advisors' Caduceus Asia Partners LP and Xueyun Cui, chairman of Kun Run Biotechnology, agreed to invest $8 million in a private placement of ...
Click on the link to read the full article at PIPEwire (This link will open in a new window)Five reasons you should care about biotechnology
22 April 2010
Jones, employed by biotechPrimer, a company whose main function is to explain biotechnology to non-scientists, spoke to journalists in advance of the ...
Click on the link to read the full article at Medill Reports: Chicago (This link will open in a new window)Sigma-Aldrich Q1 profit jumps as volumes improve
22 April 2010
NEW YORK, April 22 (Reuters) - Biotechnology company Sigma-Aldrich Corp (SIAL.O) posted better-than-expected first-quarter profit as volumes improved and ...
Click on the link to read the full article at Reuters (This link will open in a new window)Biotechnology Stocks in Focus (ANDS, GILD, BNVI, GENZ, GNVC, CELG, CTIC)
22 April 2010
COM, April 22, 2010 ) Dallas, Tx - Following were among the Biotechnology stocks whose shares were actively traded in Wednesday's session. ...
Click on the link to read the full article at Earthtimes (press release) (This link will open in a new window)Prana Biotechnology to commence Phase II Alzheimer's trial
22 April 2010
Prana Biotechnology, has announced that it is finalizing plans to commence a definitive Phase IIb trial of its lead Alzheimer's disease drug, or PBT2, ...
Click on the link to read the full article at Trading Markets (press release) (This link will open in a new window)ACTESA concludes stakeholder consultations on regional biotechnology
22 April 2010
Apart from making recommendations on policy and guidelines, the meeting also defined a bio-safety roadmap and communications strategy for biotechnology and ...
Click on the link to read the full article at Afrique en Ligue (This link will open in a new window)ABB, Credit Suisse, Nestle, Novartis: Swiss Stock Preview
22 April 2010
Actelion Ltd. (ATLN VX): Switzerland's largest biotechnology company reported higher first-quarter profit as doctors prescribed more of the Tracleer lung ...
Click on the link to read the full article at BusinessWeek (This link will open in a new window)Czarina of biotechnology
21 April 2010
So can you' Photo: Thulasi Kakkat Kiran Mazumdar-Shaw, MD and Chairman, Biocon Limited, India's pioneering biotechnology company, shares a lot about things ...
Click on the link to read the full article at The Hindu (This link will open in a new window)
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
